A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Two Sigma Advisers, LP holds 106,000 shares of JAZZ stock, worth $13.1 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
106,000
Previous 21,500 393.02%
Holding current value
$13.1 Million
Previous $2.29 Million 415.0%
% of portfolio
0.03%
Previous 0.01%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$100.57 - $116.37 $8.5 Million - $9.83 Million
84,500 Added 393.02%
106,000 $11.8 Million
Q2 2024

Aug 14, 2024

SELL
$103.94 - $118.98 $20,788 - $23,796
-200 Reduced 0.92%
21,500 $2.29 Million
Q1 2024

May 15, 2024

BUY
$115.19 - $132.77 $1.87 Million - $2.15 Million
16,200 Added 294.55%
21,700 $2.61 Million
Q4 2023

Feb 14, 2024

SELL
$114.26 - $136.0 $4.67 Million - $5.56 Million
-40,900 Reduced 88.15%
5,500 $676,000
Q3 2023

Nov 14, 2023

SELL
$122.0 - $145.31 $12 Million - $14.3 Million
-98,400 Reduced 67.96%
46,400 $6.01 Million
Q2 2023

Aug 14, 2023

SELL
$122.5 - $147.16 $5.75 Million - $6.9 Million
-46,900 Reduced 24.47%
144,800 $18 Million
Q1 2023

May 15, 2023

SELL
$133.98 - $160.47 $2.34 Million - $2.81 Million
-17,500 Reduced 8.37%
191,700 $28.1 Million
Q4 2022

Feb 14, 2023

BUY
$129.72 - $159.85 $12.2 Million - $15.1 Million
94,400 Added 82.23%
209,200 $33.3 Million
Q3 2022

Nov 14, 2022

BUY
$126.59 - $161.18 $8.34 Million - $10.6 Million
65,900 Added 134.76%
114,800 $15.3 Million
Q2 2022

Aug 15, 2022

BUY
$141.59 - $168.66 $4.63 Million - $5.52 Million
32,700 Added 201.85%
48,900 $7.63 Million
Q1 2022

May 16, 2022

BUY
$129.64 - $160.7 $1.28 Million - $1.59 Million
9,900 Added 157.14%
16,200 $2.52 Million
Q4 2021

Feb 14, 2022

BUY
$119.87 - $145.67 $755,181 - $917,720
6,300 New
6,300 $803,000
Q3 2021

Nov 15, 2021

SELL
$128.64 - $184.79 $308,735 - $443,496
-2,400 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$160.2 - $186.42 $1.28 Million - $1.49 Million
-7,985 Reduced 76.89%
2,400 $426,000
Q1 2021

May 17, 2021

BUY
$150.19 - $173.5 $1.56 Million - $1.8 Million
10,385 New
10,385 $1.71 Million
Q3 2020

Nov 16, 2020

SELL
$105.46 - $144.13 $3.83 Million - $5.23 Million
-36,285 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$95.68 - $121.88 $1.11 Million - $1.41 Million
11,585 Added 46.9%
36,285 $4 Million
Q1 2020

May 15, 2020

SELL
$87.74 - $152.74 $6.1 Million - $10.6 Million
-69,485 Reduced 73.78%
24,700 $2.46 Million
Q4 2019

Feb 14, 2020

BUY
$117.65 - $153.73 $6.98 Million - $9.13 Million
59,360 Added 170.45%
94,185 $14.1 Million
Q3 2019

Nov 14, 2019

SELL
$125.18 - $143.24 $45.2 Million - $51.8 Million
-361,285 Reduced 91.21%
34,825 $4.46 Million
Q2 2019

Aug 14, 2019

SELL
$125.55 - $144.48 $17 Million - $19.6 Million
-135,800 Reduced 25.53%
396,110 $56.5 Million
Q1 2019

May 15, 2019

BUY
$121.81 - $142.95 $39.7 Million - $46.6 Million
326,300 Added 158.7%
531,910 $76 Million
Q4 2018

Feb 14, 2019

BUY
$115.94 - $166.74 $794,536 - $1.14 Million
6,853 Added 3.45%
205,610 $25.5 Million
Q3 2018

Nov 14, 2018

SELL
$161.01 - $180.57 $6.07 Million - $6.81 Million
-37,700 Reduced 15.94%
198,757 $33.4 Million
Q2 2018

Aug 14, 2018

BUY
$146.33 - $183.18 $21.3 Million - $26.6 Million
145,300 Added 159.4%
236,457 $40.7 Million
Q1 2018

May 15, 2018

BUY
$135.59 - $157.16 $899,910 - $1.04 Million
6,637 Added 7.85%
91,157 $13.8 Million
Q4 2017

Feb 14, 2018

BUY
$131.06 - $150.39 $11.1 Million - $12.7 Million
84,520
84,520 $11.4 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.76B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.